Sort
89,613 grants matching “depression”
Patterns and Predictors of Smoking from Adolescence to Young Adulthood
$894,472Robin J Mermelstein · University Of Illinois At Chicago · P01 · FY2012 · CA
California State Univ San Marcos MBRS SCORE Program
$894,349California State University San Marcos · S06 · FY2004 · GM
Neuroimaging of Dedifferentiation and Memory Across the Lifespan
$894,213Denise Cortis Park · University Of Texas Dallas · R37 · FY2009 · AG
Consortium to improve OutcoMes in HIV/Aids, Alcohol, Aging & multi-Substance use
$893,934Amy Caroline Justice · Yale University · U24 · FY2013 · AA
Quantifying Temperature Dependence In Growth & Grazing Rates of Planktonic Herbivores
$893,886Susanne Menden-Deuer · University Of Rhode Island · · FY2017 · GEO
Behavioral epidemiology of healthy aging
$893,672Alan B Zonderman · National Institute On Aging · ZIA · FY2017 · AG
CNS Pain Mechanisms in Early Rheumatoid Arthritis: Implications for the Acute to Chronic Pain Transition
$893,626Yvonne Claire Lee · Northwestern University At Chicago · R01 · FY2020 · AR
Glucocorticoid Receptors (GR) in Mitochondria: The Role in Chronic Stress
$893,609Husseini K Manji · National Institute Of Mental Health · Z01 · FY2007 · MH
NEUROPATHOLOGICAL &GENETIC ABNORMALITIES IN DEPRESSION
$893,605University Of California Irvine · P50 · FY2003 · MH
Biased Mu-Opioid Receptor Analgesics to Prevent Overdose and Opioid Use Disorders
$893,396Lawrence C Kuo · Mebias Discovery, Inc. · UG3 · FY2018 · DA
NEUROPATHOLOGICAL &GENETIC ABNORMALITIES IN DEPRESSION
$893,081University Of California Irvine · P50 · FY2001 · MH
Actify! An mHealth mood management tool to improve population-level smoking cessation
$893,044Jaimee Heffner · Fred Hutchinson Cancer Center · U01 · FY2025 · DA
Deprescribing antipsychotics in patients with Alzheimers disease and related dementias and behavioral disturbance in skilled nursing facilities
$892,903Joshua K Lin · Brigham And Women'S Hospital · R01 · FY2023 · AG
Oral Health Advocates in Public Housing
$892,616Michelle M Henshaw · Boston University Medical Campus · U54 · FY2012 · DE
COCAINE PHARMACOTHERAPIES FOR COMORBID POPULATIONS
$892,560Yale University · P50 · FY2000 · DA
Gulf Longitudinal Follow-up (GuLF) Study
$892,530Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Palliative care intervention for socioeconomically disadvantaged cancer patients
$892,431Jennifer L. Steel · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Development of Mu Agonist Delta Antagonist Opioids as Analgesics for Chronic Pain
$892,417Subramaniam Ananthan · Southern Research Institute · R01 · FY2018 · DA
Using digital photovoice to explore the relationships between social media content and suicidality among transgender adolescents
$892,328Priya Nambisan · University Of Wisconsin Milwaukee · RF1 · FY2025 · MH
Development of an intravenous CB1 antagonist for acute cannabinoid intoxication and cannabis hyperemesis syndrome
$892,290Kenneth Cundy · Anebulo Pharmaceuticals, Inc. · U01 · FY2024 · DA
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders
$892,224Katherine Elizabeth Burdick · Brigham And Women'S Hospital · R01 · FY2021 · MH
HIV Risk Reduction for Black Drug-Using Women
$891,825University Of Pennsylvania · R01 · FY2002 · MH
Predictive tool to prevent overdose in patients treated with prescription opioids
$891,821Maciek Sasinowski · Venebio Group, Llc · R44 · FY2017 · DA
Realization of Optical Cell-based Reporters for in vivo Detection of Neuropeptides
$891,384Paul A Slesinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · MH
Realization of Optical Cell-based Reporters for in vivo Detection of Neuropeptides
$891,384Paul A Slesinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · MH